Financing Cash Flow
Merck & Co. Financing Cash Flow increased by 174.2% to $2.64B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 208.8%, from -$2.43B to $2.64B. Over 3 years (FY 2021 to FY 2024), Financing Cash Flow shows a downward trend with a 140.7% CAGR.
Analysis
How to read this metric
A large negative value typically indicates a company is returning capital to shareholders or paying down debt, while a positive value suggests the company is raising external capital to fund operations or acquisitions.
Detailed definition
This metric represents the net flow of cash between a company and its capital providers, including shareholders and lend...
Peer comparison
Large-cap peers like Microsoft or Alphabet similarly show large negative financing outflows due to aggressive share repurchase programs and dividend distributions.
cf_net_cash_from_financingHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.59B | $0.00 | $0.00 | -$3.09B | $3.09B | $0.00 | $0.00 | -$2.05B | $3.76B | -$4.27B | $2.57B | -$2.81B | $1.22B | -$2.43B | -$3.01B | -$5.76B | -$3.56B | $2.64B |
| QoQ Change | — | -100.0% | — | — | +200.0% | -100.0% | — | — | +283.0% | -213.6% | +160.1% | -209.7% | +143.2% | -299.4% | -24.1% | -91.3% | +38.2% | +174.2% |
| YoY Change | — | — | — | — | +93.6% | — | — | +33.4% | +21.8% | — | — | -37.0% | -67.6% | +43.2% | -217.3% | -104.5% | -392.4% | +208.8% |
Financing Cash Flow at Other Companies
Frequently Asked Questions
- What is Merck & Co.'s financing cash flow?
- Merck & Co. (MRK) reported financing cash flow of $2.64B in Q3 2025.
- How has Merck & Co.'s financing cash flow changed year-over-year?
- Merck & Co.'s financing cash flow increased by 208.8% year-over-year, from -$2.43B to $2.64B.
- What is the long-term trend for Merck & Co.'s financing cash flow?
- Over 3 years (2021 to 2024), Merck & Co.'s financing cash flow has grown at a 140.7% compound annual growth rate (CAGR), from -$504.00M to -$7.03B.
- What does financing cash flow mean?
- The total amount of money a company spends or receives from borrowing debt and managing its own shares and dividends.